Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

49 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Association of body mass index with clinicopathological features and survival in patients with primary invasive lobular breast cancer.
Van Baelen K, Nguyen HL, Hamy-Petit AS, Richard F, Karsten MM, Nader Marta G, Vermeulen P, Toussaint A, Reyal F, Vincent-Salomon A, Dirix L, Dordevic AD, de Azambuja E, Larsimont D, Amato O, Maetens M, De Schepper M, Geukens T, Han SN, Baert T, Punie K, Wildiers H, Smeets A, Nevelsteen I, Floris G, Biganzoli E, Neven P, Desmedt C. Van Baelen K, et al. Among authors: amato o. Eur J Cancer. 2023 Sep;191:112988. doi: 10.1016/j.ejca.2023.112988. Epub 2023 Jul 13. Eur J Cancer. 2023. PMID: 37573673 Free article.
Evolution of HER2-low expression from primary to recurrent breast cancer.
Miglietta F, Griguolo G, Bottosso M, Giarratano T, Lo Mele M, Fassan M, Cacciatore M, Genovesi E, De Bartolo D, Vernaci G, Amato O, Conte P, Guarneri V, Dieci MV. Miglietta F, et al. Among authors: amato o. NPJ Breast Cancer. 2021 Oct 12;7(1):137. doi: 10.1038/s41523-021-00343-4. NPJ Breast Cancer. 2021. PMID: 34642348 Free PMC article.
Incorporating weekly carboplatin in anthracycline and paclitaxel-containing neoadjuvant chemotherapy for triple-negative breast cancer: propensity-score matching analysis and TIL evaluation.
Dieci MV, Carbognin L, Miglietta F, Canino F, Giorgi CA, Cumerlato E, Amato O, Massa D, Griguolo G, Genovesi E, Garufi G, Giannarelli D, Tornincasa A, Trudu L, Michieletto S, Saibene T, Lo Mele M, Fassan M, Zarrilli G, Piacentini F, Bria E, Guarneri V. Dieci MV, et al. Among authors: amato o. Br J Cancer. 2023 Jan;128(2):266-274. doi: 10.1038/s41416-022-02050-8. Epub 2022 Nov 17. Br J Cancer. 2023. PMID: 36396818 Free PMC article.
Author Correction: Evolution of HER2-low expression from primary to recurrent breast cancer.
Miglietta F, Griguolo G, Bottosso M, Giarratano T, Lo Mele M, Fassan M, Cacciatore M, Genovesi E, De Bartolo D, Vernaci G, Amato O, Conte P, Guarneri V, Dieci MV. Miglietta F, et al. Among authors: amato o. NPJ Breast Cancer. 2021 Nov 24;7(1):149. doi: 10.1038/s41523-021-00359-w. NPJ Breast Cancer. 2021. PMID: 34819500 Free PMC article. No abstract available.
HER2-low-positive breast cancer: evolution from primary tumor to residual disease after neoadjuvant treatment.
Miglietta F, Griguolo G, Bottosso M, Giarratano T, Lo Mele M, Fassan M, Cacciatore M, Genovesi E, De Bartolo D, Vernaci G, Amato O, Porra F, Conte P, Guarneri V, Dieci MV. Miglietta F, et al. Among authors: amato o. NPJ Breast Cancer. 2022 May 20;8(1):66. doi: 10.1038/s41523-022-00434-w. NPJ Breast Cancer. 2022. PMID: 35595761 Free PMC article.
Correction: Incorporating weekly carboplatin in anthracycline and paclitaxel-containing neoadjuvant chemotherapy for triple-negative breast cancer: propensity-score matching analysis and TIL evaluation.
Dieci MV, Carbognin L, Miglietta F, Canino F, Giorgi CA, Cumerlato E, Amato O, Massa D, Griguolo G, Genovesi E, Garufi G, Giannarelli D, Tornincasa A, Trudu L, Michieletto S, Saibene T, Lo Mele M, Fassan M, Zarrilli G, Piacentini F, Bria E, Guarneri V. Dieci MV, et al. Among authors: amato o. Br J Cancer. 2023 Jan;128(2):398. doi: 10.1038/s41416-022-02087-9. Br J Cancer. 2023. PMID: 36460777 Free PMC article. No abstract available.
Liquid biopsy accelerates precision medicine.
Amato O, Aftimos P, Ignatiadis M. Amato O, et al. Ann Oncol. 2023 Apr;34(4):333-335. doi: 10.1016/j.annonc.2023.02.004. Epub 2023 Feb 16. Ann Oncol. 2023. PMID: 36804455 Free article. No abstract available.
49 results